Yy Group Holding [YYGH] vs Medirom Healthcare [MRM] Detailed Stock Comparison
Yy Group Holding
NASDAQ
Loading...
Medirom Healthcare
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 17 vital metrics comparison: Yy Group Holding wins in 5 metrics, Medirom Healthcare wins in 10 metrics, with 0 ties. Medirom Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Yy Group Holding | Medirom Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 20.23 | 9.47 | Medirom Healthcare |
| Price-to-Book Ratio | 11.12 | 0.02 | Medirom Healthcare |
| Debt-to-Equity Ratio | 81.32 | 400.54 | Yy Group Holding |
| EV/EBITDA | -15.19 | 12.54 | Yy Group Holding |
| Profit Margin (TTM) | -11.77% | 1.79% | Medirom Healthcare |
| Operating Margin (TTM) | -26.81% | 13.30% | Medirom Healthcare |
| EBITDA Margin (TTM) | N/A | 13.30% | N/A |
| Return on Equity | -93.74% | 22.96% | Medirom Healthcare |
| Return on Assets (TTM) | -24.14% | 0.04% | Medirom Healthcare |
| Free Cash Flow (TTM) | $-1.60M | $-12.84M | Yy Group Holding |
| 1-Year Return | 155.41% | -69.74% | Yy Group Holding |
| Price-to-Sales Ratio (TTM) | 1.85 | 0.00 | Medirom Healthcare |
| Enterprise Value | $74.33M | $25.02M | Yy Group Holding |
| EV/Revenue Ratio | 1.81 | 0.45 | Medirom Healthcare |
| Revenue per Share (TTM) | $1 | $1,625 | Medirom Healthcare |
| Earnings per Share (Diluted) | $-0.14 | $0.19 | Medirom Healthcare |
| Beta (Stock Volatility) | N/A | 0.88 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Yy Group Holding vs Medirom Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Yy Group Holding | -0.79% | -10.00% | -31.52% | 18.13% | 6.18% | 8.00% |
| Medirom Healthcare | 1.67% | -17.81% | 30.43% | 127.85% | 104.55% | 78.22% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Yy Group Holding | 155.41% | -35.71% | -35.71% | -35.71% | -35.71% | -35.71% |
| Medirom Healthcare | -69.74% | -73.66% | -87.71% | -87.71% | -87.71% | -87.71% |
Performance & Financial Health Analysis: Yy Group Holding vs Medirom Healthcare
| Metric | YYGH | MRM |
|---|---|---|
| Market Information | ||
| Market Cap | $75.88M | $14.22M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 466,130 | 13,755,920 |
| 90 Day Avg. Volume | 365,830 | 4,601,657 |
| Last Close | $1.88 | $1.83 |
| 52 Week Range | $0.72 - $3.45 | $0.34 - $8.39 |
| % from 52W High | -45.65% | -78.19% |
| All-Time High | $4.70 (Apr 22, 2024) | $19.80 (Dec 28, 2020) |
| % from All-Time High | -60.00% | -90.76% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.21% | 0.31% |
| Quarterly Earnings Growth | N/A | 0.55% |
| Financial Health | ||
| Profit Margin (TTM) | -0.12% | 0.02% |
| Operating Margin (TTM) | -0.27% | 0.13% |
| Return on Equity (TTM) | -0.94% | 0.23% |
| Debt to Equity (MRQ) | 81.32 | 400.54 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.17 | $118.11 |
| Cash per Share (MRQ) | $0.08 | $41.69 |
| Operating Cash Flow (TTM) | $-1,501,880 | $-9,014,839 |
| Levered Free Cash Flow (TTM) | $-2,963,123 | $-7,095,987 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Yy Group Holding vs Medirom Healthcare
| Metric | YYGH | MRM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 20.23 | 9.47 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| Price to Sales (TTM) | 1.85 | 0.00 |
| Price to Book (MRQ) | 11.12 | 0.02 |
| Market Capitalization | ||
| Market Capitalization | $75.88M | $14.22M |
| Enterprise Value | $74.33M | $25.02M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.81 | 0.45 |
| Enterprise to EBITDA | -15.19 | 12.54 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.88 |
| Book Value per Share (MRQ) | $0.17 | $118.11 |
Financial Statements Comparison: Yy Group Holding vs Medirom Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | YYGH | MRM |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | YYGH | MRM |
|---|---|---|
| Cash & Equivalents | $836,907 | $2.23M |
| Total Current Assets | $13.41M | $18.33M |
| Total Current Liabilities | $7.96M | $28.32M |
| Long-Term Debt | $1.13M | $13.90M |
| Total Shareholders Equity | $6.19M | $8.05M |
| Retained Earnings | $-4.29M | $1.55M |
| Property, Plant & Equipment | $129,687 | $14.04M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | YYGH | MRM |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | YYGH | MRM |
|---|---|---|
| Shares Short | 2,148 | 3,836 |
| Short Ratio | 0.01 | 0.17 |
| Short % of Float | 0.00% | 0.00% |
| Average Daily Volume (10 Day) | 466,130 | 13,755,920 |
| Average Daily Volume (90 Day) | 365,830 | 4,601,657 |
| Shares Outstanding | 36.10M | 53,492 |
| Float Shares | 10.89M | 5.81M |
| % Held by Insiders | 0.74% | 0.26% |
| % Held by Institutions | 0.00% | 0.03% |
Dividend Analysis & Yield Comparison: Yy Group Holding vs Medirom Healthcare
| Metric | YYGH | MRM |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |